Sunrest Lifescience Ltd

SUNREST

Company Profile

  • Business description

    Sunrest Lifescience Ltd is engaged in the trading business of pharmaceutical products, including capsules, tablets, syrups, ointments, gels, mouthwash, and toothpaste on a wholesale and retail basis. Its product portfolio covers categories such as anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental care, anti-inflammatory, nutraceuticals, and more. The company works with a network of suppliers and super suppliers, distributing products to chemists, hospitals, and dispensaries across multiple Indian states. Sunrest relies on both in-house manufacturing through its group company Trilend Pharmaceuticals and third-party manufacturers, emphasizing quality control and regulatory compliance.

  • Contact

    YMCA Club, Near SG Highway
    D-608 West Gate
    Near Brooklin Tower, Makarba
    Jivraj Park
    AhmedabadGJ380051
    IND

    T: +91 7929918245

    https://www.sunrestlifescience.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Pharmaceutical Retailers

    Fiscal Year End

    31 March 2026

    Employees

    210

Stocks News & Analysis

stocks

We remove our Moat Rating from ASX listed share

Despite a surging share price a weakening competitive position causes a reassessment of our view.
stocks

Best sustainable companies to own in 2026

We believe these companies’ strong ESG management practices give them a long-term advantage.
stocks

New data centre deal for ASX listed REIT

New parternship adds to a growing data centre pipeline in fiscal 2026.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,034.702.20-0.02%
CAC 408,249.9654.750.67%
DAX 4024,761.00221.660.90%
Dow JONES (US)48,382.39319.100.66%
FTSE 1009,983.7932.650.33%
HKSE26,347.248.770.03%
NASDAQ23,235.636.36-0.03%
Nikkei 22551,832.801,493.322.97%
NZX 50 Index13,587.2338.810.29%
S&P 5006,858.4712.970.19%
S&P/ASX 2008,728.602.600.03%
SSE Composite Index4,023.4254.581.38%

Market Movers